Pain During Chest Tube Withdrawal: Evaluation Using Pan Monitor
NCT ID: NCT02015858
Last Updated: 2016-10-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2013-06-30
2014-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Withdrawal of chest tube can be painful and the purpose of the study was to compare auto-evaluation of pain (visual analogic scale) and the index measured by the Pain Monitor.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Epidural analgesia
Postoperative patients with epidural analgesia
Chest drain withdrawal
Pain Monitor
Oral analgesics
Postoperative patients with oral analgesics
Chest drain withdrawal
Pain Monitor
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Chest drain withdrawal
Pain Monitor
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients able to indicate the pain score.
Exclusion Criteria
* insulin-dependent diabetes with dysautonomia,
* central or peripheral neurological disease, agitation,
* inability to understand the protocol,
* inability to use the Pain Monitor: skin abnormalities at the site of measurement, pacemaker or implantable defibrillator, condition affecting the sympathetic nervous system, tremor of the extremities,
* contra-indication to oral morphine ,
* respiratory failure, severe hepatic insufficiency, intracranial hypertension, epilepsy associations
* recent administration of neostigmine or of atropine.
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hopital Foch
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marc Fischler
Role: STUDY_CHAIR
Hôpital Foch
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hopital Foch
Suresnes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013-A00612-43
Identifier Type: OTHER
Identifier Source: secondary_id
2013/22
Identifier Type: -
Identifier Source: org_study_id